New Deal
Sasha Rosenthal-Larrea
Partner at Cravath Swaine & Moore
Lawyer
New York
Deal Bio
Awards
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Expertise (36)
Key Relationships
Announcement Date
Deal Value
Gkn (driveline Division)
Dana Incorporated
value n/a
82 dealmakers
Direct Energy
Nrg Energy
£2,840m
72 dealmakers
Scientific Games Corporation (lottery Business)
Brookfield Business Partners
£4,391m
97 dealmakers
BEHAVIOSEC
Lexisnexis Risk Solutions
9 dealmakers
Royal Circuit Solutions
Summit Interconnect
NUTRAFOL
UNILEVER
17 dealmakers
EUROTHERM
WATLOW
66 dealmakers
Yumanity Therapeutics (product Candidates)
Johnson & Johnson
£21m
11 dealmakers
Valvoline (global Products Business)
Saudi Aramco
£2,173m
88 dealmakers
Cowen
Td Bank Group
£1,062m
62 dealmakers
Atlas Air Worldwide Holdings
Jf Lehman & Company
£3,855m
74 dealmakers
Texas Capital Bank (insurance Premium Finance Business)
Afco Credit Corporation
£2,956m
18 dealmakers
Adt
State Farm Insurance Company
£1,043m
22 dealmakers
Bdt & Company
Msd Partners
15 dealmakers
Weber
Bdt Capital Partners
£1,694m
29 dealmakers
ABIOMED
£14,391m
53 dealmakers
Lifezone Metals
Gogreen Investments
£807m
40 dealmakers
ISOPLEXIS
Berkeley Lights
£47m
Portfolio Advisors
Fs Investments
49 dealmakers
College Ave Student Loans
THRIVENT
14 dealmakers
Iff (flavor Specialty Ingredients Business)
Exponent Private Equity
£183m
7 dealmakers
Human Api
10 dealmakers
Jbt Corporation (aerotech Business)
OSHKOSH
£647m
16 dealmakers
Ppg/ Entrotech Joint Venture
Ppg Industries
Route Mobile
PROXIMUS
£550m
52 dealmakers
Tabula Rasa Healthcare
Exactcare Pharmacy
£446m
31 dealmakers
Adt (commercial Business)
Gtcr
£1,254m
77 dealmakers
Omni Logistics
Forward Air Corporation
£1,648m
Ilegal Mezcal
Bacardi
45 dealmakers
The Kleinfelder Group
Lindsay Goldberg
46 dealmakers
Knight Commercial
Omers Private Equity
24 dealmakers
FRESHDIRECT
GETIR
35 dealmakers
Nfp Corp
Aon
£10,507m
87 dealmakers
REJU
Under Armour
Ambrx
£1,493m
38 dealmakers
Cymabay Therapeutics
Gilead Sciences
£3,404m
30 dealmakers